Skip to content
Open access

Gray matter atrophy mediates the association between cerebral hypometabolism and cognitive impairment in Alzheimer’s disease

Sep 2026 · Frontiers in Neurology · Vol 17 · 0 citations · 74 references
Medicine

TL;DR

Overall, the association between cerebral metabolic dysfunction and cognitive impairment appeared to be predominantly direct, with limited evidence supporting a mediating role of regional GMV.

Abstract

Objective Alzheimer’s disease (AD) is characterized by amyloid deposition, brain hypometabolism, gray matter atrophy and cognitive decline, yet their causal interactions are poorly defined. This multimodal PET/MRI study explored regional gray matter volume (GMV) loss and glucose hypometabolism in AD patients, and clarified their correlations with distinct cognitive deficits alongside mediating pathways. Methods 134 probable dementia patients were split into AD and non-AD dementia cohorts based on 18F-AV45 PET amyloid-β (Aβ) load, all receiving structural MRI, 18F-FDG and 18F-AV45 PET scans. We compared intergroup GMV and metabolic discrepancies, analyzed imaging-cognition correlations adjusted for clinical and demographic confounders, and implemented mediation models to test whether GMV bridges cerebral metabolism and cognition. Results AD patients exhibited prominent regional GMV shrinkage and FDG hypometabolism in vulnerable brain regions relative to non-AD dementia subjects. Covariate-adjusted analyses linked both imaging biomarkers to domain-specific cognitive performance. Primary mediation analyses showed that regional GMV significantly mediated the associations between FDG metabolism and visuospatial, executive, and language function, accounting for 40.36, 35.60, and 49.99% of the total effects, respectively. Reverse mediation models identified only a weak indirect effect of right superior temporal gyrus metabolism on the association between right inferior parietal lobule GMV and visuospatial ability, accounting for 13.26% of the total effect. Moreover, after multiple-imputation sensitivity analyses, most indirect effects became unstable or nonsignificant, suggesting that the FDG metabolism–cognition association is predominantly direct, with limited evidence for GMV mediation. Conclusion Integrated PET/MRI revealed AD-related patterns of regional atrophy and hypometabolism. Overall, the association between cerebral metabolic dysfunction and cognitive impairment appeared to be predominantly direct, with limited evidence supporting a mediating role of regional GMV.

Read PDF

Similar papers

Open access Oct 2026

Regional atrophy and hypoperfusion mediate the association between affective symptoms and cognitive impairment in Alzheimer's disease.

OBJECTIVE Affective symptoms are common and associated with poor cognitive outcomes in patients with Alzheimer's disease (AD); however, their underlying neural correlations remain poorly understood. METHODS This study included 105 patients with AD. Patients were classified into an AD with affective symptoms (AD-A) gr...

Jin-Cao Wang, Guan-Qun Zhao, Qing-Zheng Lu et al. · 0 citations
Open access Sep 2026

Cerebral perfusion correlates of domain-specific cognitive function in Alzheimer's disease and dementia with Lewy bodies

Distinct patterns of cerebral perfusion-cognition relationships characterize AD and DLB, reflecting differential regional vulnerabilities underlying cognitive decline, which may contribute to improved understanding of the pathophysiology underlying cognitive decline and support disease monitoring.

Yume Koizumi, Yoshikazu Nakano, Mitsuyoshi Tamura et al. · 0 citations
Sep 2026

Comparison of baseline characteristics between cognitively normal and mild cognitive impairment and association of white matter hyperintensity trajectories with diagnostic outcomes, cognition, and amyloid-β protein: A longitudinal study

WMH baseline and trajectory changes are key risk factors for CN cognitive decline and WMH trajectory changes are linked to cognitive function and brain Aβ deposition.

W. Ba, Cui-Ping Bao, Ying-Xun Gong et al. · 0 citations
Open access Oct 2026

Sex‐specific brain reserve and progression from mild cognitive impairment to Alzheimer's disease dementia

Findings suggest that females may tolerate greater pathology at early stages but experience faster neurodegeneration later, supporting sex‐specific disease trajectories and highlighting the need for sex‐informed biomarkers.

Xu-Lin Liu, S. D. de Boer, M. Tartaglia · 0 citations
Open access Sep 2026

T1 mapping in Alzheimer’s disease: a quantitative MRI study with amyloid-PET correlation

Quantitative T1 mapping (qT1) is a magnetic resonance imaging (MRI) biomarker of brain microstructural changes; however, its application in Alzheimer disease (AD) remains limited. We compared cortico-limbic qT1 values between patients with AD and healthy controls (HCs) and examined their relationship with amyloid burde...

L. Gualco, N. Montobbio, M. Losa et al. · 0 citations
Open access Sep 2026

Medial Temporal Atrophy and Posterior Cingulate Structural Covariance in Mild Cognitive Impairment.

BACKGROUND Mild cognitive impairment (MCI) is associated with structural abnormalities in regions vulnerable to Alzheimer's disease, but the relative contributions of medial temporal, posterior midline, and association cortices remain unclear. We compared regional gray matter volumes between individuals with MCI and co...

Xiao-Ming Yang, Jian Lyu, Ju-Bo Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.